Objective: To evaluate the hemolysis biomarkers of packed red blood cells transfused by two different linear peristaltic infusion pumps at two infusion rates. Method: An experimental and randomized study was designed simulating the clinical practice of transfusion. Two linear peristaltic infusion pumps from different manufactures were studied in triplicate at 100 mL/h and 300mL/h infusion rates. The chosen hemolysis biomarkers were total hemoglobin, free hemoglobin, hematocrit, potassium and degree of hemolysis. They were analyzed before and after each infusion. Results: Potassium showed statistically significant variations in all scenarios of the experiment (P<0.010). In a separated analysis, potassium increased mainly at 300mL/h rate (P=0.021) and free hemoglobin had significant variation when comparing infusion pumps from different manufacturers (P=0.026). Although hematocrit, total hemoglobin and degree of hemolysis had increased after infusion, no statistically significance variations were identified.
Introduction
Packed red blood cell (RBC) transfusion is often indicated as supportive care in different clinical scenarios of anemia as a purpose of increasing the oxygen-carrying capacity of erythrocytes (1) (2) . Hemolysis is one of the clinical complications from blood transfusion therapy and it is related to functional reduction of hemoglobin. Red cell damage may release potassium and free hemoglobin to the patient plasma, possibly causing clinical complications in renal and cardiovascular systems (3) (4) .
Packed RBC is often delivered by gravitational infusion sets and in some scenarios with additional aid of positive or negative external pressures sets (5) (6) . However, the safety of these pressure devices is not clear, once there are several factors that can influence erythrocyte integrity (3, 6) .
Infusion pumps (IPs) are among the most commonly used devices for controlling fluid infusion.
Several models of IPs are available in the market with different propulsion mechanisms, such as peristaltic, shuttle, piston cassette, syringe and diaphragm (6) (7) .
Electronic infusion devices have brought innovation
to the intravenous therapy through rigorous fluid controlling, security in pressure and air alarms; however, the concern with the safety of this equipment in blood transfusions remains (3) (4) 8) . The IPs mechanism can also be influenced by the infusion rate, age of RBC and preservative solution, different types of intravenous sets, needle gauge and in-line filters (7) (8) .
The existing evidence does not precisely define the result of the mechanical actions of infusion devices over the red blood cells. Also, there are few and conflicting studies about the impact of using IPs on the integrity of RBCs (8) .
Peristaltic mechanisms were evaluated in some studies and the results revealed major risk of hemolysis (8) (9) (10) (11) (12) .
However, other studies with linear peristaltic IP showed low risk of hemolysis and concluded that the evaluated IPs were suitable for transfusion when considering limit of the degree of hemolysis at 0.8%, recommended by Brazilian, European and Canadian regulatory agencies (13) (14) (15) (16) .
Infusion rate is also a variable mentioned in different studies, and it may have effect on the integrity of RBCs. Researchers have observed higher degree of hemolysis when there are higher RBC infusion rates in peristaltic IPs (17) (18) . In experiments with IPA, blood-filtering kits were suitable to the IP, with a total length of 230 centimeters (cm), and 16mL was the volume needed to fill the lumen.
Volumetric linear
For the IPB, there were no corresponding bloodfiltering kits supplied by manufacturer. Therefore, the manufacturer recommended the use of extension tubes from other manufacturers, which were connected to the device for blood components. The total length of the infusion lines, including the extender and the indicated device, totaled 270cm, being 26mL the volume needed to fill the lumen.
The devices were randomized at each infusion rate and each packed RBC was directed to three IPs. 
Results
This study covered the assessment of five markers in the different phases of the experiment conducted in each device (IPA and IPB); and in the rates of 100 mL/h and 300 mL/h selected in each IP.
The outcome variables are regarded in Table 1 that shows the variation of hemolysis biomarkers. Table 1 shows that hematocrit varied from 67%
to 76%, and that the lowest hematocrit concentration was found in the 300mL/h infusion rate, in both devices.
Total hemoglobin presented mean variation from 22.8g/ dL to 30.8g/dL in experiments conducted with IPA, whereas the variation went from 23.5g/dL to 29.8g/dL in the experiment conducted with IPB.
Free hemoglobin presented values from 0.046g/dL to 0.651g/dL in the IPA, and from 0.047g/dL to 0.694g/ dL in the IPB, thus reaching higher levels in the rate of 300ml/h, both in the IPA and IPB.
The minimum degree of hemolysis found in the experiment phases with IPA was 0.06%, at infusion rate of 100mL/h; the maximum degree of hemolysis was 0.81%, The effect of infusion system (C2) and infusion pump (V) on the RBC (C1), regardless of the flow and IP, are summarized in Table 2 .
The percentage of hematocrit, the total hemoglobin concentration, the free hemoglobin and the degree of hemolysis did not present significant Multiple comparisons were performed with potassium in the three moments of the experiment according to the Bonferroni method, as showed in Figure 1 . These multiple comparisons applied to potassium concentration showed statistically significant increase between the control samples of the packed RBC and post-infusion samples in all infusion rates (P =0.018).
These results, shown in Table 2 and Figure 1 , indicate the potassium was significantly increased by the IPs.
The level of hemolysis markers of RBC was assessed according to the IPs (IPA and IPB) and infusion rates (100 and 300 mL/h), as shown in Table 3 .
Potassium concentration increased regardless on the programed infusion rate, but with a significant increase on experiments at rate of 300mL/h (P=0.021). The other markers did not present statistically significant variation regardless of the infusion rate.
The five selected markers were assessed in the experiment phases according to the IP, as shown in Table 4 . Table 3 -Hemolysis markers of packed red blood cells (RBC) according to the central and dispersion trend measures applied to the control sample, collected in the packed red blood cells bag (C1); the infusion system (C2); and the after infusion (V), according to the flows 100 mL/h and 300 mL/h. São Paulo, SP, Brazil, 2015 the most prone to hemolytic events, suggesting that the damage caused to the erythrocytes may occur due to the device mechanism (7) (8) .
The RBC quality control is a rigorous phase aimed at assessing the blood component preparation process.
Quality is evaluated through previously set indicators by extrapolating the results of the referred production of the analyzed fraction. Quality control analyses in blood banks must be carried out in at least 1% of the production or in 10 units per month, according to the value representing most of the production. It is worth highlighting that not all blood component units transfused to patients are subjected to quality control assessment (9) (10) 15) .
The present study showed that the hematocrit and the total hemoglobin remained within the quality control standard. The degree of hemolysis, according to Brazilian legislation, is set at a maximum of 0.8%, for the last storage day of RBC preserved in CPDA-1 solution (19) . The reference values of potassium and free hemoglobin have not been stablished in literature, so they are not routinely assessed in blood banks. These markers were assessed in the present study according to their alteration during the experiment phases. Although free hemoglobin is not routinely assessed, the analysis thereof is an evaluation stage of degree of hemolysis in some analysis techniques used by blood banks (15) .
The degree of hemolysis found in the experiments ranged from 0.06% to 0.83%. Two values above the recommended ones -0.81% and 0.83% -were observed in the current study, both in the experiments using infusion rate at 300mL/h (Table 1 ). Data collection evidenced that the 0.83% value was found at the C1 moment. Despite the obtainment of blood products is well set by the sanitation and health authorities, there may be cases in which the blood component presents reference values different from those set by the quality control. The multidisciplinary team may not be aware of it, since the checking is not performed throughout the whole production. Thus, there is concern with the fact that the lack of analyses in markers throughout the whole production may result in damages to the patient.
The prolonged storage time of RBC could be an additional factor that contributes to increasing hemolysis markers. The intracellular concentration of potassium decreases as the storage time increases, whereas the extracellular concentration grows (16, (20) (21) .
Studies have recommended that blood transfusions in some populations, such as newborns and children, must be performed with recently collected RBCs (at least seven days), in order to preserve the original features of the blood component and to avoid the damaging effects caused by its storage (23) (24) . Potassium concentration presented statistically significant changes (P <0.010) ( Table 2) cases and in hypercalcemia cases described in the literature. It is recommended RBC infusion of at most 5mL kg -1 minute -1 to avoid hypercalcemia (22) (23) . Some publications suggest that hemolytic effects are more prone to occur in higher rates (8, 17) .
The analyses of the markers according to the infusion pump (Table 4) presented statistically significant increase in the hemolysis markers, such as free hemoglobin in IPA (p=0.022) and potassium in IPB (p=0.026). These changes could be possibly explained by the infusion mechanism of the device.
Other studies corroborate the potassium increase in experiments carried out with infusion pump and relate higher values to longer storage time (11) (12) (13) (14) (15) (16) (17) . A publication described extracellular potassium increase according to the storage time and to the infusion mechanism of the device, regardless of the selected flow (11) . High potassium levels used as hemolysis indicators have been described in studies associated with severe adverse events, such as arrhythmias and cardiocirculatory arrest, in massive and fast blood transfusion performed during emergency situations (21) (22) (23) .
The other markers, such as hematocrit, increased in all the phases of the conducted experiments, but such increase was not statistically significant.
Hematocrit has been associated with the viscosity of the blood components in some publications; thus, the higher the hematocrit value is, the more viscous the blood product (18) (19) . The free hemoglobin marker had increased in all experiment scenarios. These findings may lead to reflection about the occurrence of changes in the erythrocytes membrane from the mechanism of the infusion pump, infusion accessories and different infusion flows. Publication investigating non-immune-mediated hemoglobinuria in pediatric patients found greater results of free hemoglobin using a particular infusion pump, mainly in RBC units with higher hematocrit. Then, it was implemented a corrective action plan to prevent and minimize the risk of mechanical hemolysis by adopting RBC units with lower hematocrit and replacing their infusion pumps after analyzing the biomarkers (24) .
Comparisons between the studied linear peristaltic 
Conclusion
Hemolysis risk induced by a linear peristaltic infusion pumps was identified in this study by an increase in free hemoglobin and potassium markers.
Potassium appeared to be an important parameter to assess the fragility of the plasmatic membrane of erythrocytes. There was also a significant increase in evolution of the experiments when it was assessed in all scenarios, as well as greater increase predisposition at flow of 300mL/h. As the potassium biomarker is often increased in aged packed red blood cells, we do not recommend using them in this scenario. Additional studies must be conducted on this theme.
